Established beneficial effects of NuSHs in MASH GLP-1RAs MASH is a complex liver disease driven by obesity, metabolic syndrome, and genetic factors
Important Safety Information GLP-1 agonists, including Wegovy, Zepbound, and Saxenda, may cause serious side effects including possible thyroid tumors, including cancer
Journal of Nutritional Science and Vitaminology, 60 (1), 2227
MEN 2 is a hereditary syndrome characterized by MTC, pheochromocytoma, and parathyroid abnormalities, caused by mutations in the RET proto-oncogene
Acknowledgements This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF- 2022M3E5E8081191 to C.-K.P.) and (NRF- 2021R1A5A2030333 to Y.H.K.), both of which are funded by the Korean government